Toggle Menu
Stocknear
ctrl
K
/
Search
Popular
KO
Coca Cola Company
Stock
TSLA
Tesla Inc
Stock
AMD
Advanced Micro Devices
Stock
SPY
SPDR S&P 500 ETF Trust
ETF
NVDA
Nvidia
Stock
Start Trial
Login
Watchlist
Price Alert
Alignment Healthcare Inc.
(ALHC)
NASDAQ: ALHC · Real-Time Price · USD
15.86
-0.44
(-2.70%)
At close:
Sep 05, 2025, 3:59 PM
15.86
0.00%
After-hours:
Sep 05, 2025, 04:10 PM EDT
Overview
Financials
Statistics
Metrics
Forecast
Dark Pool
Options
Insider
Dividends
History
Profile
Overview
Health Care Capitation
Health Care, Premium
Alignment Healthcare Revenue Breakdown
Period Ending
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
Sep 30, 2022
Jun 30, 2022
Mar 31, 2022
Dec 31, 2021
Sep 30, 2021
Jun 30, 2021
Mar 31, 2021
Health Care Capitation Revenue
33.19M
32.37M
32.17M
35.07M
15.17M
14.56M
15.07M
14.41M
14.11M
14.52M
15.3M
2.29M
Health Care Capitation Revenue Growth
+2.54%
+0.61%
-8.27%
+131.25%
+4.14%
-3.38%
+4.57%
+2.17%
-2.85%
-5.11%
+569.17%
n/a
Health Care, Premium Revenue
425.82M
417.87M
424.7M
399.74M
344.93M
345.42M
351.11M
330.88M
283.96M
278.75M
n/a
n/a
Health Care, Premium Revenue Growth
+1.90%
-1.61%
+6.25%
+15.89%
-0.14%
-1.62%
+6.11%
+16.52%
+1.87%
n/a
n/a
n/a
Operating Expense Breakdown
Period Ending
Jun 30, 2025
Mar 31, 2025
Dec 31, 2024
Sep 30, 2024
Jun 30, 2024
Mar 31, 2024
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
Sep 30, 2022
Jun 30, 2022
Mar 31, 2022
Dec 31, 2021
Sep 30, 2021
Jun 30, 2021
Mar 31, 2021
Dec 31, 2020
Sep 30, 2020
Jun 30, 2020
Mar 31, 2020
Selling, General, and Administrative Revenue
103.8M
103.83M
102.13M
90.87M
87.86M
90.51M
83.74M
83.09M
70.2M
70.41M
83.23M
76.45M
61.67M
74.29M
78.08M
76.85M
71.15M
64.91M
51.12M
38.79M
33.7M
32.79M
Selling, General, and Administrative Revenue Growth
-0.03%
+1.67%
+12.39%
+3.42%
-2.93%
+8.09%
+0.78%
+18.36%
-0.30%
-15.40%
+8.86%
+23.96%
-16.99%
-4.85%
+1.61%
+8.01%
+9.61%
+26.99%
+31.77%
+15.12%
+2.78%
n/a
Research and Development Revenue
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
Research and Development Revenue Growth
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
Add to Watchlist
✕